Raymond James Trust N.A. Decreases Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Raymond James Trust N.A. cut its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 24.9% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,008 shares of the company’s stock after selling 4,970 shares during the period. Raymond James Trust N.A.’s holdings in HCA Healthcare were worth $4,822,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in HCA. Atlantic Edge Private Wealth Management LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth approximately $27,000. Bangor Savings Bank lifted its position in shares of HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after acquiring an additional 45 shares in the last quarter. MFA Wealth Advisors LLC acquired a new position in HCA Healthcare in the 2nd quarter valued at about $27,000. Unique Wealth Strategies LLC purchased a new position in shares of HCA Healthcare during the second quarter valued at approximately $28,000. Finally, GPS Wealth Strategies Group LLC grew its stake in HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after acquiring an additional 71 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the sale, the senior vice president now owns 17,755 shares of the company’s stock, valued at $6,303,912.75. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the sale, the senior vice president now directly owns 17,755 shares in the company, valued at $6,303,912.75. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Kathleen M. Whalen sold 2,987 shares of the business’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the completion of the sale, the senior vice president now owns 9,454 shares in the company, valued at $3,436,623.54. The disclosure for this sale can be found here. In the last three months, insiders have sold 8,844 shares of company stock worth $3,185,932. 1.60% of the stock is owned by corporate insiders.

HCA Healthcare Stock Performance

HCA stock traded down $0.39 during mid-day trading on Monday, reaching $388.39. The company had a trading volume of 92,616 shares, compared to its average volume of 1,129,547. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $391.00. The stock’s 50-day simple moving average is $344.47 and its two-hundred day simple moving average is $331.03. The stock has a market capitalization of $101.72 billion, a P/E ratio of 19.38, a P/E/G ratio of 1.39 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, beating the consensus estimate of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The company had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. During the same quarter last year, the business earned $4.29 earnings per share. HCA Healthcare’s revenue was up 10.3% compared to the same quarter last year. Research analysts anticipate that HCA Healthcare, Inc. will post 22.43 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.68%. The ex-dividend date is Monday, September 16th. HCA Healthcare’s payout ratio is currently 13.16%.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on HCA shares. Oppenheimer raised their price target on HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. TD Cowen lowered their price target on HCA Healthcare from $371.00 to $360.00 and set a “buy” rating for the company in a research report on Tuesday, April 30th. Cantor Fitzgerald reissued an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a research report on Monday, August 19th. UBS Group raised their target price on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research note on Wednesday, August 14th. Finally, SVB Leerink upped their price target on HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. Four research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $356.17.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.